Cargando…
Is CHEK2 a moderate-risk breast cancer gene or the younger sister of Li-Fraumeni?
The CHEK2 gene is mostly considered as a moderate breast cancer gene with the result that many clinicians have a narrow focus. We present the 10-year journey of a man who had five different cancers and had iterative genetic testing including for Li-Fraumeni syndrome, eventually to discover a pathoge...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7477966/ https://www.ncbi.nlm.nih.gov/pubmed/32900738 http://dx.doi.org/10.1136/bcr-2020-236435 |